Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML

📅 27/04/2026 05:20 📰 norfolkdailynews 👁️ 7 lectures 🌍 États-Unis 📂 Santé

LUND, SE / ACCESS Newswire / April 27, 2026 / Cantargia AB (Nasdaq Stockholm:CANTA), a clinical-stage biotechnology